Title : Poster (46) Major hallmarks in alzheimer's disease (ad) can beneficially be modulated by M1 muscarinic agonists - an added value vs. cholinesterase inhibitors - |
Author(s) : Fisher A , Brandeis R , Pittel Z , Haring R , Sparks L , Beach TG , Bons N , Maestre-Frances N , Bar-Ner N , Kliger-Spatz M , Natan N , Marcovitch I , Hartmann T |
Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :345 , 2004 |
PubMedID: |
Title : Beta-amyloids, tau hyperphosphorylation and cognition are beneficially affected by M1 muscarinic agonists. - |
Author(s) : Pittel Z , Haring R , Bons N , Bar-Ner N , Sonego H , Natan N , Marcovitch I , Brandeis R |
Ref : Cholinergic Mechanisms, CRC Press :345 , 2004 |
PubMedID: |
Title : M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy - Fisher_2003_J.Mol.Neurosci_20_349 |
Author(s) : Fisher A , Pittel Z , Haring R , Bar-Ner N , Kliger-Spatz M , Natan N , Egozi I , Sonego H , Marcovitch I , Brandeis R |
Ref : Journal of Molecular Neuroscience , 20 :349 , 2003 |
Abstract : |
PubMedSearch : Fisher_2003_J.Mol.Neurosci_20_349 |
PubMedID: 14501019 |